Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2022-09-28 00:00:00 ET · period of report 2022-09-26 · accession 0001808805-22-000101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-28 | 2022-09-26+ | NAUT | Sankar Subramanian | Senior VP, Product Development | P - Purchase | $2.03 | +15.0K | 91.2K | +20% | +$30.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-26 | P | A | 10,000 | $2.03 | 86,250 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $2.00 to $2.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-09-27 | P | A | 5,000 | $2.03 | 91,250 | D | — | — | (F3) Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.02 to $2.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |